IRONWOOD PHARMACEUTICALS, INC. — Net Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/b0b1a14c-95a6-44de-8cbc-c3f6b1401ae5/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $24.0M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-050325 |
| FY 2024 | $880.0k | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-004072 |
| FY 2023 | $-1.0B | 2023-01-01 – 2023-12-31 | evidence 0001104659-26-050325 |
| FY 2022 | $175.1M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-001462 |
| FY 2021 | $528.4M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-001368 |
| FY 2020 | $106.2M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-001136 |
| FY 2019 | $21.5M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-000779 |
| FY 2018 | $-282.4M | 2018-01-01 – 2018-12-31 | evidence 0001558370-19-001005 |
| FY 2017 | $-116.9M | 2017-01-01 – 2017-12-31 | evidence 0001558370-18-000927 |
| FY 2016 | $-81.7M | 2016-01-01 – 2016-12-31 | evidence 0001558370-18-000927 |
| FY 2015 | $-142.7M | 2015-01-01 – 2015-12-31 | evidence 0001558370-18-000927 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
IRONWOOD PHARMACEUTICALS, INC. — all facts · Revenue · Operating Income